Oritavancin In Vitro Activity Against a Collection of Gram-Positive Clinical Isolates Causing Bone and Joint Infections, Including Osteomyelitis, in United States and European Hospitals (2012-2016)
Oritavancin In Vitro Activity Against a Collection of Gram-Positive Clinical Isolates Causing Bone and Joint Infections, Including Osteomyelitis, in United States and European Hospitals (2012-2016). Lead author: R Mendes, presented at ASM Microbe 2017, June 1-5, New Orleans, Louisiana, USA
# Friday-342
